Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

DOJ Targets Neurofeedback Billing in $15 Million Behavioral Health Fraud Case

By Anna Timmerman & Allyson M. Maur on April 28, 2025
Email this postTweet this postLike this postShare this post on LinkedIn

On March 6, 2025, federal prosecutors charged a Minnesota couple with orchestrating a $15 million healthcare fraud scheme involving overbilling and submission of false claims for neurofeedback and other behavioral health services performed by a network of behavioral health clinics. This newly unsealed federal indictment underscores the Department of Justice’s increasing focus on fraud involving neurofeedback and other emerging behavioral health treatments.

Read on to learn more about the federal indictment and what it portends for behavioral health practices and potential investors.

Photo of Anna Timmerman Anna Timmerman

Anna’s practice focuses on healthcare transactional and regulatory matters for a variety of healthcare providers, including dental support organizations, management services organizations, ambulatory surgery centers and surgery center management companies, behavioral health companies and hospitals, as well as private equity sponsors in their…

Anna’s practice focuses on healthcare transactional and regulatory matters for a variety of healthcare providers, including dental support organizations, management services organizations, ambulatory surgery centers and surgery center management companies, behavioral health companies and hospitals, as well as private equity sponsors in their platform and subsequent transactions.

Read more about Anna TimmermanEmail
Show more Show less
Photo of Allyson M. Maur Allyson M. Maur

Allyson advises on regulatory issues affecting diagnostics developers, biopharma manufacturers, and clinical laboratories, including CLIA/CLEP and FDA regulatory advice, MLR and MRC review of marketing and promotional materials, clinical studies, global data privacy issues, ethics & compliance, commercial contracting, commercial litigation and more.

Read more about Allyson M. MaurEmail
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    The FCA Insider
  • Organization:
    McGuireWoods LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo